OSRH · XBRL financial data
OSR Health financial statements, every fiscal year
The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (OSRH's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Feb 14, 2024 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Revenue | — | — | 3,530 | 2,906 |
| Cost of revenue | — | — | 2,719 | 2,313 |
| Gross profit | — | — | 811 | 593 |
| Research and development | — | — | 161 | 318 |
| Selling, general and administrative | 35 | — | 12,503 | 18,929 |
| General and administrative | — | — | 3,525 | — |
| Operating income (loss) | (35) | — | (3,525) | (18,336) |
| Interest income | — | — | 1,450 | 64 |
| Interest expense | — | — | 43 | 506 |
| Income tax expense (benefit) | — | — | 296 | (1,830) |
| Net income (loss) | (35) | — | (2,411) | — |
| Earnings per share, basic USD per share | (0.01) | — | (0.54) | (0.92) |
| Earnings per share, diluted USD per share | (0.01) | — | (0.54) | (0.80) |
| Weighted average shares, basic thousands of shares | 1,500 | — | 4,482 | 19,515 |
| Weighted average shares, diluted thousands of shares | 1,500 | — | 4,482 | 22,560 |
Balance sheet
CSVFiscal years (OSRH's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Feb 14, 2024 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | 125 | — | 66 | 1,700 |
| Accounts receivable | — | — | 904 | 319 |
| Inventory | — | — | 922 | 196 |
| Total current assets | 125 | — | 455 | 2,817 |
| Property and equipment, net | — | — | 2 | 169 |
| Right-of-use asset | — | — | 78 | 60 |
| Goodwill | — | — | 24,354 | 24,950 |
| Total assets | 1,226 | — | 2,303 | 171,238 |
| Accrued liabilities | — | — | 460 | 958 |
| Total current liabilities | 1,263 | — | 6,719 | 17,165 |
| Long-term debt | — | — | 498 | — |
| Lease liability, non-current | — | — | 33 | 13 |
| Total liabilities | 1,263 | — | 8,789 | 44,201 |
| Accumulated deficit | (63) | — | (8,334) | (37,170) |
| Total stockholders' equity | (38) | — | (8,333) | — |
| Total liabilities and equity | 1,226 | — | 2,303 | 171,238 |
| Common shares outstanding (cover page) thousands of shares | 9,055 | 5,623 | 19,277 | 33,125 |
Cash flows
CSVFiscal years (OSRH's year ends in late December)
| In thousands of dollars | Dec 31, 2022 | Feb 14, 2024 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Net income (loss) | (35) | — | (2,411) | — |
| Net cash from operating activities | (4) | — | (2,188) | (4,328) |
| Net cash from investing activities | — | — | 35,908 | (2,643) |
| Proceeds from issuing common stock | — | — | — | 4,796 |
| Share repurchases | — | — | 36,232 | — |
| Proceeds from long-term debt | — | — | 237 | — |
| Net cash from financing activities | 124 | — | (33,669) | 8,368 |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| OSR Health | 1,500 | 316 | (2,421)* | 35.1M | 0.6 quarters | 10-QJun 30, 2026 |
| Sintx Technologies | 3,590 | 452 | (2,767)* | 6.7M | 1.3 quarters | 10-QJun 30, 2026 |
| Tenon Medical | 1,677 | 1,279 | (2,758)* | 667,047 | 0.6 quarters | 10-QJun 30, 2026 |
| Retractable Technologies | 2,641 | 7,201 | (1,732)* | 29.9M | 1.5 quarters | 10-QJun 30, 2026 |
| SeaStar Medical Holding | 6,959 | 615 | (2,994)* | 4.4M | 2.3 quarters | 10-QJun 30, 2026 |
| ENvue Medical | 1,084 | 239 | (2,691)* | 11.1M | 0.4 quarters | 10-QJun 30, 2026 |
| Bone Biologics | 6,088 | not reported | (532)* | 3.4M | 9.8 quarters | 10-QSep 30, 2026 |
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| Medinotec | 2,584 | 3,201 | 108* | 11.8M | — | 10-QAug 31, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.